Prime Highlights-
- Jordan’s Ram Pharmaceutical and Saudi Arabia’s Cigalah Healthcare launched a new investment partnership
- Minister Tareq Abu Ghazaleh called it a model for deeper Arab economic integration
Key Facts-
- Partnership aims to strengthen Jordan’s pharmaceutical sector and expand Jordanian-Saudi cooperation
- Move ties into Jordan’s Economic Modernization Vision, which prioritizes pharmaceuticals as a growth sector
Background-
Jordan’s Ram Pharmaceutical Industries and Saudi Arabia’s Cigalah Healthcare have launched a new investment partnership aimed at boosting value-added investment in Jordan and strengthening economic cooperation between the two countries.
Minister of Investment Tareq Abu Ghazaleh attended the launch ceremony and called Jordanian-Saudi relations a model of deep, lasting ties. The partnership, he noted, reflects both the strength of bilateral economic relations and the confidence private companies place in each other’s markets.
For Abu Ghazaleh, the deal marks a step toward closer Arab economic integration in what he called a highly strategic sector. Investing in pharmaceuticals and healthcare means investing directly in people, quality of life, and a society’s ability to withstand shocks and crises. A strong pharmaceutical industry, he added, has become essential for health security and broader national resilience.
Jordan has spent decades building up its pharmaceutical manufacturing base, and its products now reach markets well beyond the region. Under the government’s Economic Modernization Vision, pharmaceuticals continue to be treated as a priority sector for driving growth and creating skilled jobs.
The partnership also signals confidence in Jordan’s investment climate, from its legal framework and skilled workforce to its infrastructure and market access. Abu Ghazaleh congratulated both companies, expressing hope that the deal would inspire similar Arab partnerships going forward.
Attendees at the launch said the agreement would strengthen Jordan-Saudi economic ties and open new paths for regional integration. The move comes as pharmaceuticals draw growing global attention as a sector tied to health security, supply chains, and technology transfer.
The partnership brings together two established players with strong footprints across Arab and international pharmaceutical and healthcare markets.
